Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.46-0.74 (-4.07%)
At close: 04:00PM EDT
17.46 0.00 (0.00%)
After hours: 04:23PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
109,136
96,148
42,087
25,000
0
Cost of Revenue
3,616
2,932
225
-
-
Gross Profit
105,520
93,216
41,862
-
-
Operating Expenses
Research Development
233,645
257,040
198,970
157,610
82,887
Selling General and Administrative
130,624
136,253
114,082
68,116
21,212
Total Operating Expenses
364,269
393,293
313,052
225,726
104,099
Operating Income or Loss
-258,749
-300,077
-271,190
-200,726
-104,099
Interest Expense
-
0
0
67
84
Income Before Tax
-258,186
-299,964
-266,489
-192,256
-99,854
Income from Continuing Operations
-258,186
-299,964
-266,489
-192,256
-99,854
Net Income
-258,186
-299,964
-266,489
-192,256
-99,854
Net Income available to common shareholders
-258,186
-299,964
-266,489
-192,256
-99,854
Basic EPS
-
-5.16
-4.78
-4.48
-2.82
Diluted EPS
-
-5.16
-4.78
-4.48
-2.82
Basic Average Shares
-
58,084
55,781
42,869
35,390
Diluted Average Shares
-
58,084
55,781
42,869
35,390
EBITDA
-
-296,950
-264,184
-191,359
-99,453